“The outlook revision reflects our assessment of Phoebe’s improved overall financial performance, solid balance sheet metrics and our expectation that operating improvement will continue,” said S&P analyst Margaret McNamara.
More articles on healthcare finance:
Uninsured rate in Mass. reaches historic low
Wis. requests $450M funding increase to support Medicaid
Erlanger reports net surplus, gives 3,700 employees bonuses
